skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical held NABOTA Symposium to commemorate first ever permit in advanced nation for domestic botulinum toxin
Date 2018-11-20 Hit 1637
News List
Prev Daewoong Pharmaceutical presented its vision and R&D capacity at the ‘5th China Healthcare Summit’
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval